Skip to content
Second Genome Inc. logo

Second Genome Inc. Alternatives & Competitors

12 companies similar to Second Genome Inc. — Discovering and developing transformational precision therapies.

Companies similar to Second Genome Inc.

Avidity Biosciences, Inc. logo — alternative to Second Genome Inc.

Avidity Biosciences, Inc.

At Avidity, we are developing a new class of oligonucleotide-based therapies.

VG Life Sciences logo — alternative to Second Genome Inc.

VG Life Sciences

Developing lifesaving therapies for drug-resistant cancers and autoimmune diseases through...

AlphaBiomics logo — alternative to Second Genome Inc.

AlphaBiomics

The Precision Medicine Company

Altis Biosystems logo — alternative to Second Genome Inc.

Altis Biosystems

Capturing the Complexity of the Human Gut

Rival Readout

Competing with Second Genome Inc.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
BiomX (NYSE: PHGE) logo — alternative to Second Genome Inc.
Advenchen Laboratories, LLC logo — alternative to Second Genome Inc.

Advenchen Laboratories, LLC

Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter...

Elevation Oncology logo — alternative to Second Genome Inc.

Elevation Oncology

We are focused on discovering and developing selective cancer therapies to treat patients...

bit.bio logo — alternative to Second Genome Inc.

bit.bio

The Cell Coding Company

Synnovation Therapeutics logo — alternative to Second Genome Inc.

Synnovation Therapeutics

A precision oncology company focused on small molecule therapies optimized to target key d...

Pear Bio logo — alternative to Second Genome Inc.

Pear Bio

Patient-centered cancer precision medicine

Eikon Therapeutics logo — alternative to Second Genome Inc.

Eikon Therapeutics

Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and develo...

Blueprint Medicines logo — alternative to Second Genome Inc.

Blueprint Medicines

Striving to improve and extend patients' lives

About Second Genome Inc.

Second Genome Inc. is a pioneering player in the biotech sector, focusing on the development of precision therapies derived from microbiome science. Since its founding in 2009, Second Genome has demonstrated its expertise by advancing a pipeline of novel therapies geared towards addressing serious diseases.

Business keywords

Precision Therapies, Microbiome Science, Drug Discovery, Innovation, Medicine, Research, Therapeutic Products, Inflammation, Metabolic Diseases, Biotechnology Research, Microbiome Analysis, Human Health

Frequently Asked Questions

Companies similar to Second Genome Inc. include Avidity Biosciences, Inc., VG Life Sciences, AlphaBiomics, Altis Biosystems, BiomX (NYSE: PHGE). They work in Biotechnology and Health Care and share Second Genome Inc.'s focus on drug discovery, inflammation and therapeutic products.
Bounce Watch lists 12 companies that share Second Genome Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.
Second Genome Inc. is a pioneering player in the biotech sector, focusing on the development of precision therapies derived from microbiome science. Since its founding in 2009, Second Genome has demonstrated its expertise by advancing a pipeline of novel therapies geared towards addressing serious diseases.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Second Genome Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Second Genome Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout